Skip to content

Biosimilars & Specialty Generics

Supporting your Biosimilar project throughout the extensive analytical & development pathway


Comprehensive Subject Matter Expertise and Integrated Solutions

The development of biosimilars requires a significant investment and risk, but they are vital for R&D as they have an opportunity to provide competition in the market and expand patient access to critical medicines. As healthcare professionals are at the forefront of patients’ care, it is of utmost importance that they have access to reliable information on biosimilars & specialty generics medicines: what they are and what scientific principles support their clinical development, approval, and safety monitoring.

SanaClis was a Proud Sponsor of the Global Generics and Biosimilars Awards 2022 in Frankfurt

The Global Generics and Biosimilars Awards celebrate the greatest achievements and innovations across the development, authorization, marketing and distribution of global off-patent pharmaceuticals. The event provides a unique opportunity for the industry to come together to discuss future opportunities and challenges and shine a light on the companies and individuals driving positive change. The SanaClis team was delighted to sponsor and  present the prestigious Biosimilar Initiative of the Year category.

Find out more

Speak to an Expert

Reach out to our team of experts to discuss your project needs.

Contact Us


Latest articles